Cargando…
Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson’s Disease?
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder worldwide. Clinically, it is characterized by severe motor complications caused by a progressive degeneration of dopaminergic neurons (DAn) and dopamine loss. Current treatment is focused on mitigating the symptoms thro...
Autores principales: | Vilaça-Faria, Helena, Salgado, António J., Teixeira, Fábio G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406999/ https://www.ncbi.nlm.nih.gov/pubmed/30717429 http://dx.doi.org/10.3390/cells8020118 |
Ejemplares similares
-
Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson’s Disease
por: Teixeira, Fábio G., et al.
Publicado: (2020) -
Mesenchymal stem cell-derived exosomes: a possible therapeutic strategy for repairing heart injuries
por: Zhu, Zeshu, et al.
Publicado: (2023) -
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases
por: Lou, Guohua, et al.
Publicado: (2017) -
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors
por: Ghasempour, Elham, et al.
Publicado: (2022) -
New therapeutic approaches of mesenchymal stem cells-derived exosomes
por: Janockova, Jana, et al.
Publicado: (2021)